Approval · Notice of Compliance 29879 · 2023
ZOMIG: Notice of Compliance 29879
Issued January 11, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29879
- Date
- January 11, 2023
- Company
- Xediton Pharmaceuticals Inc.Oakville, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in Product Ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZOMIG | 02238660 | Marketed |
| ZOMIG NASAL SPRAY | 02248992 | Marketed |
| ZOMIG NASAL SPRAY | 02248993 | Marketed |
| ZOMIG RAPIMELT | 02243045 | Marketed |
Medicinal ingredients
- ZOLMITRIPTAN 2.5 MG per TAB
- ZOLMITRIPTAN 2.5 MG per ACT
- ZOLMITRIPTAN 5 MG per ACT